The COVID-19 cardiovascular legacy: long COVID and its complications

Cardiovascular medicine

23 July 2024

COVID-19, and specifically long COVID, is associated with an increased risk of cardiovascular disease. Listen as Amitava Banerjee describes his work in this area, especially the STIMULATE-ICP trial, which looks at long COVID’s physiological and social impact. Find out about what the NHS is doing to tackle COVID-19 and its associated cardiovascular and metabolic abnormalities.

Share this episode:

Speaker

Professor Amitava Banerjee, Professor of Clinical Data Science, University College London, and Honorary Consultant Cardiologist, UCLH and Barts Health NHS Trust

Learning objectives

Learn how cardiovascular disease is both a risk factor and an outcome of the COVID-19 infection.
Know the evidence behind multi-organ and metabolic damage in long COVID, as well as the prevention of long COVID.
Understand the clinical trials that have successfully incorporated a learning health system approach to improve the recovery of people living with long COVID.